Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 138,167 shares at $13.83 ($1.9M) on 2026-01-16, disclosed to the SEC on 2026-01-20.
Seasonal sale ($1.9M) by Co-Chief Executive Officer — this insider has traded AMLX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.59 | 136,193 | $1.9M | 98.5% |
| 2 | $13.83 | 1,974 | $27K | 1.5% |
| Total | $13.59 avg | 138,167 | $1.9M | 100% |
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $856K | — | Filing → |